RxDoctor Payments Data

Jeannine Lafrance

Adult Health · New Iberia, LANPI 1932355021

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $925, 9.7 times the $96 reported in 2021.

$2,820in general payments, 2019–2025

Across 149 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$361
  • Merck$303
  • Johnson & Johnson$300
  • Takeda Pharmaceuticals U.S.A., Inc.$194
  • AstraZeneca$184
  • Incyte Corporation$157
  • plus $1K from 37 others

What the payments were for

  • Food & beverage$2,820100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,820 in reported general payments places this provider in the 70th percentile of 203 adult health providers in Louisiana.

See all adult health providers in Louisiana

Other adult health in New Iberia

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →